Edition:
United Kingdom

XOMA Corp (XOMA.OQ)

XOMA.OQ on NASDAQ Stock Exchange Global Market

16.19USD
19 Sep 2018
Change (% chg)

$-0.01 (-0.06%)
Prev Close
$16.20
Open
$16.18
Day's High
$16.76
Day's Low
$15.94
Volume
8,502
Avg. Vol
39,548
52-wk High
$37.25
52-wk Low
$15.39

Latest Key Developments (Source: Significant Developments)

XOMA Reports Qtrly Loss Per Share $0.46
Wednesday, 9 May 2018 

May 9 (Reuters) - XOMA Corp ::XOMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 REVENUE $500,000 VERSUS $300,000.Q1 REVENUE VIEW $2.7 MILLION -- THOMSON REUTERS I/B/E/S.QTRLY LOSS PER SHARE $0.46.  Full Article

XOMA Announces Exclusive License Agreement For XOMA 358 With Rezolute Inc.
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - XOMA Corp ::XOMA ANNOUNCES EXCLUSIVE LICENSE AGREEMENT FOR XOMA 358 WITH REZOLUTE, INC..XOMA CORP - UNDER LICENSE AGREEMENT, CO IS ENTITLED TO RECEIVE UP TO APPROXIMATELY $240 MILLION IN EXCHANGE FOR GLOBAL XOMA 358 RIGHTS.XOMA CORP - TO RECEIVE PAYMENTS AS REZOLUTE ACHIEVES SPECIFIC MILESTONES ASSOCIATED WITH FINANCING ACTIVITIES, CLINICAL DEVELOPMENT SUCCESS​, OTHERS.XOMA-‍TERMS OF AGREEMENT INCLUDE ALLOCATION OF $5 MILLION IN SHARES OF REZOLUTE TO CO,$13 MILLION IN CASH,STOCK TO BE PAID AS REZOLUTE COMPLETES SOME MILESTONES​.XOMA SAYS IS ALSO ENTITLED TO RECEIVE LOW SINGLE-DIGIT ROYALTIES ON NET SALES OF AB101, OTHER PRODUCTS DEVELOPED FROM CERTAIN OF REZOLUTE PLATFORMS.XOMA CORP - REZOLUTE IS RESPONSIBLE FOR ALL DEVELOPMENT, REGULATORY, MANUFACTURING AND COMMERCIALIZATION ACTIVITIES UNDER LICENSE.XOMA SAYS REZOLUTE PLANS TO ADVANCE XOMA 358'S CLINICAL DEVELOPMENT IN 2018.XOMA CORP - ELIGIBLE TO RECEIVE ROYALTIES RANGING FROM HIGH SINGLE-DIGITS TO MID-TEENS ON NET SALES OF XOMA 358.  Full Article

Xoma posts Q3 revenue of $36.2 million
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Xoma Corp :Xoma reports third quarter 2017 financial results.Q3 revenue $36.2 million versus $600,000.Q3 revenue view $690,000 -- Thomson Reuters I/B/E/S.Qtrly diluted net income per share available to common stockholders $1.98.  Full Article

BRIEF-XOMA Reports Qtrly Loss Per Share $0.46

* QTRLY LOSS PER SHARE $0.46 Source text for Eikon: Further company coverage: